Consolidated Statements of Operations - USD ($)	12 Months Ended
	Nov. 30, 2015	Nov. 30, 2014
Income Statement [Abstract]
Revenues	$ 604,953	$ 491,319
Cost and expenses:
Costs of services	457,206	287,028
Selling, general and administrative	773,106	1,054,867
Total costs and expenses	1,230,312	1,341,895
Loss from operations	(625,359)	(850,576)
Other income (expense):
Interest expense	(1,414,029)	(1,838,375)
Amortization of deferred finance costs	(5,305)	(83,714)
Other, net	390	121,399
Gain on troubled debt restructuring	3,868,321
Impairment of intangible assets	(1,393,690)
Impairment of investment (total $820,000 less $600,000 previously recognized in other comprehensive income)	(220,000)
Gain on sale of subsidiary	2,571	640,621
Gain on settlement of liabilities	2,328,876	213,961
Gain (loss) on change in value of derivative liabilities	(2,264,449)	1,337,886
Total other income	902,685	391,778
Net income (loss)	277,326	(458,798)
Loss from noncontrolling interest	208,396
Net income (loss) attributable to Pervasip Corp.	485,722	(458,798)
Accretion of preferred stock dividends	100,710
Net income (loss) attributable to common stockholders	$ 385,012	$ (458,798)
Basic earnings per share	$ 0.00	$ 0.00
Diluted earnings per share	$ 0.00	$ 0.00
Weighted average number of shares outstanding: Basic	3,079,122,127	980,488,901
Weighted average number of shares outstanding: Diluted	22,427,520,720	980,488,901